How many institutions held CVSI - CV Sciences, Inc. - Common Stock, $0.0001 par value per share in Q4 2022?

1 institutional investor reported CVSI - CV Sciences, Inc. - Common Stock, $0.0001 par value per share for Q4 2022. Use the holders table for investor-level position and value details.

CV Sciences, Inc. - Common Stock, $0.0001 par value per share (CVSI)

Q: What does CUSIP 126654102 represent in this 13F holders report?

CUSIP 126654102 is the security identifier for CVSI - CV Sciences, Inc. - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

CUSIP: 126654102

Q4 2022 13F Holders as of 31 Dec 2022

Security type / class: Equity / Common Stock, $0.0001 par value per share
Total 13F shares: 100
Total 13F value: $3
Share change: +100
SEC-reported price per share: $0.03
Number of holders: 1
Value change: +$3
Number of buys: 1
Shares outstanding: 203,425,275

Security key

126654102

Report period

Q4 2022

Institutions

Top holders

CVSI full security history Ownership snapshot Full 13F holder table CV Sciences, Inc. SEC filings CV Sciences, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CVSI - CV Sciences, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Joseph C. Maroon MD

Disclosed value leader

—

Comparable rows

0/4

Latest evidence

02 Jun 2021

3/4/5 Some rows are evidence-backed but not safely comparable across classes. 4 rows are not safely comparable across share classes.

Quick read

SEC ownership evidence is available, but the rows are not safely comparable across share classes.

0 of 4 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Joseph C. Maroon MD's linked filing trail.

Detailed SEC evidence table Showing 1-4 of 4 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Joseph C. Maroon MD	3/4/5 Director 3/4/5	— mixed-class rows	— 1,066,116 shares mixed-class rows	—	02 Jun 2021
Elizabeth Ann Altman	3/4/5 Director 3/4/5	— class O/S missing	— 275,000 shares	—	02 Jun 2021
Paul Blake	3/4/5 Director 3/4/5	— class O/S missing	— 275,000 shares	—	02 Jun 2021
Terri F. Graham	3/4/5 Director 3/4/5	— class O/S missing	— 275,000 shares	—	02 Jun 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

100

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

Q4 2022 holders

Holder diff

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 value	Q4 2022 value	Value change	Value Chg %